FDA Advisory Panel Recommends Approval of Avedro’s CXL Platform

A joint FDA advisory panel recommended approval of Avedro’s combined riboflavin ophthalmic solutions and ultraviolet (UV) light irradiation for corneal collagen cross-linking. The recommendation is the last step before the FDA renders a decision on March 29. The FDA’s Dermatologic and Ophthalmic Drugs Advisory...